1. Home
  2. CHCO vs BHVN Comparison

CHCO vs BHVN Comparison

Compare CHCO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • BHVN
  • Stock Information
  • Founded
  • CHCO 1957
  • BHVN 2013
  • Country
  • CHCO United States
  • BHVN United States
  • Employees
  • CHCO 963
  • BHVN N/A
  • Industry
  • CHCO Major Banks
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • BHVN Health Care
  • Exchange
  • CHCO Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • CHCO 1.7B
  • BHVN 1.9B
  • IPO Year
  • CHCO N/A
  • BHVN 2017
  • Fundamental
  • Price
  • CHCO $120.10
  • BHVN $8.34
  • Analyst Decision
  • CHCO Hold
  • BHVN Strong Buy
  • Analyst Count
  • CHCO 3
  • BHVN 14
  • Target Price
  • CHCO $132.33
  • BHVN $49.23
  • AVG Volume (30 Days)
  • CHCO 73.6K
  • BHVN 2.3M
  • Earning Date
  • CHCO 10-22-2025
  • BHVN 11-11-2025
  • Dividend Yield
  • CHCO 2.93%
  • BHVN N/A
  • EPS Growth
  • CHCO 11.27
  • BHVN N/A
  • EPS
  • CHCO 8.68
  • BHVN N/A
  • Revenue
  • CHCO $307,880,000.00
  • BHVN N/A
  • Revenue This Year
  • CHCO $9.60
  • BHVN N/A
  • Revenue Next Year
  • CHCO $1.36
  • BHVN $2,079.03
  • P/E Ratio
  • CHCO $13.70
  • BHVN N/A
  • Revenue Growth
  • CHCO 6.33
  • BHVN N/A
  • 52 Week Low
  • CHCO $102.22
  • BHVN $12.79
  • 52 Week High
  • CHCO $137.28
  • BHVN $54.98
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 47.74
  • BHVN 24.55
  • Support Level
  • CHCO $116.04
  • BHVN $16.80
  • Resistance Level
  • CHCO $119.31
  • BHVN $18.57
  • Average True Range (ATR)
  • CHCO 2.37
  • BHVN 1.18
  • MACD
  • CHCO 0.05
  • BHVN -0.77
  • Stochastic Oscillator
  • CHCO 45.98
  • BHVN 5.02

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: